Research Use Only. GHK-Cu 50mg is supplied strictly for in-vitro laboratory research. It is not intended for human consumption, therapeutic, diagnostic, or clinical use. The information below summarises published preclinical research; key sources are listed at the end. This content is not medical advice. Ascend Peptides UK accepts no liability for misuse of this product
GHK-Cu is a widely studied copper-binding peptide in biochemical research. First isolated from human plasma in the early 1970s, this naturally occurring tripeptide-copper complex has since been the subject of an extensive body of published laboratory research spanning skin biology, wound-healing models, anti-inflammatory signalling, and gene-expression studies.
This guide is written for two audiences. For laboratory scientists and research professionals, it provides a thorough scientific overview of this compound — its structure, mechanism of action, and applications in controlled research settings. For scientifically engaged individuals (qualified researchers, laboratory professionals, and academic or institutional research settings) who follow developments in peptide biochemistry and skin research science, it offers an accessible explanation of why this copper peptide complex has attracted such sustained scientific attention.
Ascend Peptides UK supplies GHK-Cu 50mg as a research peptide for laboratory investigation only. All content in this guide is provided strictly for scientific and educational purposes. This compound is not intended for human consumption, clinical use, or therapeutic application of any kind.
What Is GHK-Cu? Structure, Origin, and Unique Properties
GHK-Cu is a naturally occurring tripeptide-copper complex found in human plasma, saliva, and urine. The peptide component GHK consists of three amino acids: glycine (Gly), histidine (His), and lysine (Lys). The Cu suffix denotes its association with a copper (II) ion, which the peptide binds with high affinity through three nitrogen atoms — the N-terminal amine, a backbone amide nitrogen and the histidine imidazole nitrogen.[2]
This copper-binding characteristic is central to the compound’s biochemical identity. Copper is an essential trace mineral involved in a wide range of enzymatic processes in biological systems, including collagen synthesis, superoxide dismutase activity, and angiogenesis. The ability of the GHK tripeptide to bind copper, and its proposed role in copper transport, have made it a subject of considerable research interest in fields ranging from dermatology research to wound biology and gene regulation studies.
What sets this compound apart from many other research peptides is its notably broad influence on cellular behaviour in laboratory models. Published research has documented that GHK can up- or down-regulate at least 4,000 human genes,[1] a gene-expression screening result that has drawn interest from several research disciplines. It describes which genes change in the test system, not a biological outcome.
Mechanism of Action: How GHK-Cu Behaves in Laboratory Models
Several mechanisms have been proposed for GHK-Cu in laboratory models. Some are better supported than others, and most come from cell-culture or animal studies. Understanding which is which is important for researchers designing experiments that incorporate this copper peptide complex as a research tool.
Mechanisms discussed in the published literature include:
-
Proposed copper-carrier role: GHK binds copper(II) tightly, and it has been proposed that it can deliver copper to copper-dependent enzymes such as lysyl oxidase (collagen and elastin cross-linking) and superoxide dismutase. This is a hypothesis discussed in reviews rather than an established mechanism.[1]
-
Collagen and extracellular matrix regulation: In cultured fibroblasts, GHK-Cu was reported to stimulate collagen synthesis, starting at picomolar concentrations with a maximum near 1 nM.[3] Reviews also describe effects on glycosaminoglycans, proteoglycans and matrix metalloproteinases.[1]
-
Antioxidant and anti-inflammatory signalling: Some laboratory studies report effects on inflammatory and oxidative-stress signalling. These findings are not covered by the references in this guide and should be checked against the primary literature before they inform a study design.
-
Angiogenesis research: Reviews describe GHK attracting endothelial and immune cells to sites of injury in wound models.[1] Claims about specific growth-factor pathways should be checked against the primary studies.
-
Gene expression modulation: Pickart and colleagues report that GHK can up- or down-regulate at least 4,000 human genes.[1] This is a gene-expression result, not evidence of any particular biological effect.
These mechanisms have been studied predominantly in in vitro cell culture models and animal research models. This compound is supplied strictly for research purposes, and none of this research constitutes clinical evidence of efficacy in human subjects.
Research Applications of GHK-Cu 50mg in Laboratory Settings
The breadth of published research on this compound reflects its versatility as a laboratory research tool. Here are the primary disciplines in which it has been applied in controlled scientific settings:
1. Skin Biology and Dermatological Research
Skin biology is the area most often discussed in the GHK-Cu literature. Laboratory work has centred on fibroblasts, including collagen synthesis[3] and other extracellular matrix components, and reviews also cover skin-repair models.[1] GHK-Cu is listed with Ascend Peptides UK’s skin and cellular research peptides.
2. Wound Healing Biology Research
Wound models are a central theme of the GHK literature. Reviews describe effects on collagen and other matrix components and the recruitment of immune and endothelial cells to injury sites in animal models.[1] The original collagen study also noted that a GHK sequence occurs within type I collagen and could be released at a wound site.[3]
3. Anti-Inflammatory and Antioxidant Research
Some laboratory studies have examined GHK-Cu in inflammatory and oxidative-stress models. The references in this guide do not establish effects on specific cytokines or antioxidant enzymes, so none are listed here. Researchers working in this area should rely on the primary literature.
4. Hair Follicle Biology Research
Hair follicle research on GHK-Cu is limited. The review by Pickart and colleagues mentions faster healing of hair follicles, among other tissues, in an animal wound model.[1] This is a much smaller literature than the fibroblast and wound-model work.
5. Gene Expression and Genomics Research
Pickart and colleagues report that GHK can up- or down-regulate at least 4,000 human genes.[1] These are gene-expression results. They show which genes change in the test system, not that any particular biological effect follows.
6. Nerve-Cell Research (Limited Evidence)
A small number of laboratory studies have looked at GHK in nerve-cell models. This is an early, limited literature that is not reviewed in this guide, and it should not be read as evidence of a protective effect.
GHK-Cu 50mg vs GHK-Cu 100mg: Choosing the Right Format
Ascend Peptides UK supplies GHK-Cu in both 50mg and 100mg formats. Selecting the appropriate quantity depends on the scale and duration of the research programme:
-
GHK-Cu 50mg is suited to smaller-scale studies, preliminary investigations, method development, and research programmes that are in the early stages of incorporating this compound into their experimental design. It minimises initial investment whilst allowing researchers to validate their experimental approach.
-
GHK-Cu 100mg is the appropriate choice for established research programmes with higher throughput requirements, concentration-response studies requiring a range of concentrations, or multi-arm studies comparing this compound against other variables. It offers better cost efficiency per milligram and reduces sourcing frequency for active programmes.
Both formats are supplied as lyophilised powder; in-stock orders placed before 3pm (Mon–Fri) are dispatched the same working day. The main practical advantage of the larger format is quantity: an extended study can draw more material from one vial, which allows a greater number of single-use aliquots. Where batch-to-batch variability matters to the design, record the batch reference of the material received.
Sourcing GHK-Cu 50mg in the UK: What to Look For
When evaluating a GHK-Cu supplier, the following documentation is worth checking:
-
HPLC purity documentation: A batch-specific Certificate of Analysis should state the HPLC purity, the measured content, the method and the batch number. There is no single legal purity standard for research peptides, so compare the figures with your own study requirements. Purity and content are different measurements.
-
Identity confirmation: Mass spectrometry can confirm identity. The free GHK peptide is about 340.4 g/mol and the 1:1 copper complex about 401.9 g/mol.
-
Lyophilised format: Research peptides are usually supplied as freeze-dried powder. Storage conditions should come from the manufacturer’s specification for the product.
-
Batch traceability: Full batch records, including synthesis parameters, purification chromatograms, and QC release documentation, are often requested for institutional procurement and published research referencing.
-
Research-only labelling: All legitimate skin research peptide products must carry clear research-use-only designations with no health, cosmetic, or clinical claims.
-
UK-based dispatch: Sourcing from a UK-based peptide distributor reduces transit time.
At Ascend Peptides UK, our GHK-Cu 50mg is supplied as part of our comprehensive range of research peptides. Ascend sends samples to Janoshik for independent analysis and publishes the returned certificates on its CoA page. The current GHK-Cu certificate covers one tested vial of the 100mg format; no certificate has been published for the 50mg format yet. In-stock orders placed before 3pm (Mon–Fri) are dispatched the same working day from the UK.
Preparing GHK-Cu 50mg: Scope of This Guide
GHK-Cu 50mg is supplied as a lyophilised powder in a sealed vial. GHK-Cu is generally described as water-soluble, but Ascend Peptides UK does not publish reconstitution, solvent, mixing or in-use instructions: how the material is prepared, aliquoted and stored is a decision for your own validated laboratory protocol. Storage requirements for the supplied vial are currently being verified with the manufacturer; the current position is on the GHK-Cu 50mg product page.
Regulatory Compliance and Responsible Research
Ascend Peptides UK supplies GHK-Cu for in-vitro laboratory research only. It is not a licensed medicine in the UK, it is not approved for human consumption, and it must not be used in any clinical, therapeutic, cosmetic or diagnostic context. Medicines for human use are regulated in the UK under the Human Medicines Regulations 2012, with the MHRA as the regulator.
All purchasing researchers and institutions are fully responsible for ensuring their acquisition and use of this compound complies with applicable UK legislation and any relevant institutional ethics or procurement requirements. Ascend Peptides UK provides research-only labelled products and makes no health, cosmetic, or clinical claims about any compound in our range.
Conclusion
GHK-Cu is a well-studied copper-binding tripeptide. The strongest laboratory evidence concerns its copper chemistry and its effects on fibroblasts and collagen. Other areas, such as inflammation, hair follicles and nerve cells, rest on a smaller or less direct literature. It is relevant to skin biology, wound-model and gene-expression research, provided claims are checked against the primary sources.
For UK researchers and laboratories seeking a reliable source of GHK-Cu 50mg, Ascend Peptides UK supplies this compound for laboratory research, with same working-day UK dispatch on in-stock orders placed before 3pm (Mon–Fri).
Whether you are establishing a new research programme around this copper peptide complex, or incorporating GHK-Cu into an existing investigation, our team at Ascend Peptides UK is ready to support your laboratory with clearly documented research compounds.
Frequently Asked Questions About GHK-Cu 50mg Research Peptide
Q: What is GHK-Cu 50mg used for in research?
Q: What does GHK-Cu stand for?
Q: Is GHK-Cu a natural or synthetic compound?
Q: What is the difference between GHK-Cu 50mg and GHK-Cu 100mg?
Q: Is GHK-Cu legal to buy in the UK?
Q: How does GHK-Cu work in laboratory research models?
Q: How should GHK-Cu 50mg be stored?
Q: Does Ascend publish preparation instructions for GHK-Cu 50mg?
Q: What purity is required for research-grade GHK-Cu?
Q: Where can I buy GHK-Cu 50mg research peptide in the UK?
Scientific references
- Pickart L, Vasquez-Soltero JM, Margolina A. (2015). GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration. Biomed Res Int. 2015:648108.
- Hureau C, et al. (2011). X-ray and solution structures of Cu(II) GHK and Cu(II) DAHK complexes: influence on their redox properties. Chem Eur J. 17(36):10151-60.
- Maquart FX, Pickart L, Laurent M, Gillery P, Monboisse JC, Borel JP. (1988). Stimulation of collagen synthesis in fibroblast cultures by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+. FEBS Lett. 238(2):343-6.
DISCLAIMER
All products supplied by Ascend Peptides UK are intended strictly for research purposes only. They are not intended for human consumption or for any therapeutic, diagnostic, or clinical use. None of the items offered are classified as medicinal products by the MHRA. It is the buyer’s responsibility to ensure all purchases comply with applicable laws and regulations. Ascend Peptides UK accepts no liability for misuse.